Prevention is Better Than Cure: The Costs of the Pandemic Accord

By Thanusha Pillay

June 4, 2024

Introduction

Following the 77th World Health Assembly, the 194 WHO member states committed to the historic milestone of finalising the Pandemic Accord within the next year. By agreeing on certain amendments to the International Health Regulations (IHR), the WHO and its member states express their commitment to prioritise solidarity and fairness in improving access to medical supplies and funding. Consequently, this involves creating a Coordinating Financial Mechanism (CMF) to aid developing countries in accessing funds for core capacities and emergencies. However, the complexities of financing pandemic governance pose a significant challenge to the implementation of these commitments.

Challenges in Financing Pandemic Governance

Low- and middle-income countries are hesitant to embrace costly capacity-building obligations without concrete financial support from wealthier nations. Conversely, higher-resourced countries face internal political obstacles, hindering financial commitments due to taxpayer scrutiny and competing demands for development resources. This disparity in financial capacities exacerbates the already fragmented landscape of global health financing initiatives.

Impact of Pandemics on the Global Economy

Pandemic prevention and preparedness is measured in billions of US dollars, but pandemic recovery is measured in trillions. Currently, the global economic toll of the COVID-19 pandemic is projected to reach an eye-watering US$15.8 trillion by the end of 2024. Alternatively, significantly reducing transmission of new diseases from tropical forests would cost up to US$30.8 billion, roughly 500 times less than the economic losses from fighting COVID-19. One study explained that investing up to $130 billion over the next two years, and $50 billion annually thereafter would significantly reduce the likelihood of future pandemics. Sadly, pandemics have a long-lasting affect on the global economy, counter decades of societal progress, and disproportionately affect lower-income countries. Strengthened financing can boost global resilience against pandemics and lessen their disproportionate impact on vulnerable populations.

Proposed Financing Mechanisms

Three key financing mechanisms are under scrutiny: the Pandemic Accord, IHR, and the WHO. Importantly, the draft Pandemic Accord introduces crucial yet expensive capacity-building commitments. These necessitate innovative financing strategies such as domestic funding, leveraging grants, loans, and debt relief to mobilise financial resources effectively. Additionally, the creation of the CMF aims to harmonise financing efforts for both the IHR and Pandemic Accord, acknowledging the interconnected nature of their obligations.

Recommendations for Strengthening Global Health Financing

  1. Establishing a Standing Financing Committee under the Pandemic Accord to enhance financial oversight and coordination.
  2. Introducing assessed contributions as a sustainable financing source for the CMF to ensure reliable funding.
  3. Implementing robust financial forecasting mechanisms for day zero surge responses to enhance emergency preparedness.
  4. Designating the WHO as the coordinating authority for global health financing to streamline efforts and prevent fragmentation.
  5. Ensuring sustainable financing for the WHO to empower the organisation in fulfilling its critical role in global health governance.

Conclusion

Investing in robust financing mechanisms for global health governance is not just a financial imperative but a moral obligation to safeguard global health security. By addressing the challenges of financing pandemic governance, we can build a more resilient and equitable world prepared to confront future health crises effectively.

Reference url

Recent Posts

prior authorization reforms
     

Streamlining Prior Authorization Reforms: Impacts and Insights for HEOR

🚀 Are prior authorizations stalling care delivery in the U.S. healthcare system?

The HHS has launched an ambitious collaboration with major insurers to reform prior authorization processes across Medicare Advantage, Medicaid, and commercial plans. With a goal to standardize submissions by 2027 and significantly reduce requirements by 2026, this initiative promises to accelerate care decisions and enhance transparency.

Dive into the details of these pivotal reforms and discover their potential to streamline healthcare and improve patient outcomes.

#SyenzaNews #HealthcareInnovation #healthcare #healthcarepolicy

private health funding
    

Private Health Funding Under South Africa’s National Health Insurance Act

🚀 Update on NHI in South Africa.

In their insightful article, Solanki et al. discuss the complexities of private health funding amidst the nation’s National Health Insurance Act. They discuss two key scenarios: a passive approach that risks the sustainability of the private sector and an active reform strategy that could ensure a smoother transition to universal coverage.

Curious about how these strategies could reshape healthcare access and costs in South Africa? Don’t miss out on this critical analysis!

#SyenzaNews #HealthEconomics #HealthcarePolicy

drug price transparency
     

Impending Net Drug Price Transparency Regulation in the U.S.

💡 Are you ready for a potential game-changer in drug pricing transparency?

CMS Administrator Mehmet Oz has hinted at a new rule aimed at enforcing stricter disclosures for drug prices, requiring healthcare companies to reveal actual transaction costs. This could reshape how price transparency is managed across the industry and challenge pharmacy benefit managers to rethink rebate practices.

Curious about how this will impact healthcare economics and what it means for drug affordability? Dive into the article for all the insights!

#SyenzaNews #healthcare #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.